Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HSP90AA1 | P07900 | 1/20 | 0.37 |
| ▸ | NUDT1 | P36639 | 1/20 | 0.34 |
| ▸ | BACE1 | P56817 | 1/20 | 0.34 |
| ▸ | PSMB5 | P28074 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6762900 | 0.84 | NUDT1 (0.35) | HSP90AA1NUDT1BACE1PSMB5 | |
| SCHEMBL4606879 | 0.82 | NUDT1 (0.33) | HSP90AA1NUDT1BACE1PSMB5 | |
| SCHEMBL4607045 | 0.77 | ALDH1A1 (0.39) | — | |
| SCHEMBL4604409 | 0.76 | HSP90AA1 (0.50) | HSP90AA1NUDT1BACE1 | |
| SCHEMBL11158718 | 0.76 | HSP90AA1 (0.41) | HSP90AA1NUDT1BACE1 | |
| SCHEMBL8512038 | 0.75 | NUDT1 (0.36) | HSP90AA1NUDT1BACE1PSMB5 | |
| SCHEMBL1245161 | 0.75 | NUDT1 (0.45) | HSP90AA1NUDT1BACE1PSMB5 | |
| SCHEMBL4463657 | 0.74 | HSP90AA1 (0.40) | HSP90AA1NUDT1BACE1 | |
| SCHEMBL4464457 | 0.74 | HSP90AA1 (0.40) | HSP90AA1NUDT1BACE1 | |
| SCHEMBL4467698 | 0.74 | HSP90AA1 (0.40) | HSP90AA1NUDT1BACE1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1336597-B1 | Hydroxyphenyl adamantanes and process for the production of the same | HONSHU CHEMICAL IND (JP) | 2008-07-16 | — | — | EP | disclosed |
| US-6720460-B2 | FORMING HEAT RESISTANT, MECHANICAL STRENGTH POLYMER ADDITIVES; ACID CATALYZED REACTION OF ADAMANTANE DIOL OR TRIOL WITH PHENOLIC DERIVATIVE | HONSHU CHEMICAL INDUSTRY CO., LTD. (JP) | 2004-04-13 | — | — | US | disclosed |
| US-20030187307-A1 | Hydroxyphenyl adamantanes and process for the production of the same | HONSHU CHEMICAL INDUSTRY CO., LTD. (JP) | 2003-10-02 | — | — | US | disclosed |
| EP-1336597-A1 | Hydroxyphenyl adamantanes and process for the production of the same | Honshu Chemical Industry Co., Ltd. (JP) | 2003-08-20 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030187307-A1 | Hydroxyphenyl adamantanes and process for the production of the same | CYP8B1, DHPS, P4HA1 | HSP90AA1 1741/4885NUDT1 312/4885BACE1 6/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.